STADA: Purchase of a generics business in Switzerland successfully concluded
31/01/2012
STADA: Purchase of a generics business in Switzerland successfully concluded
Related Posts
STADA invests more than €85m in Saudi Arabia manufacturing hub
STADA invests more than €85m in Saudi Arabia manufacturing hub
STADA and Bio-Thera receive European Marketing Authorization for Gotenfia, a Biosimilar to Simponi
STADA and Bio-Thera receive European Marketing Authorization for Gotenfia, a Biosimilar to Simponi
STADA’s Head of Communications Frank Staud additionally leads Global Government Affairs
STADA’s Head of Communications Frank Staud additionally leads Global Government Affairs
